Pharmaceutical Investing Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes
Pharmaceutical Investing Alder BioPharmaceuticals, Inc. Announces Offering of $200 Million of Convertible Senior Notes Due 2025
Quidel Receives FDA Clearance for Solana(R) Molecular Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus
Stellarex™ ILLUMENATE Pivotal Results Are Top-tier in the Most Complex Patient Group Studied in DCB IDE Trials
Cloud Investing AMD Announces Public Offerings of $600 Million of Common Stock and $450 Million of Convertible Senior Notes
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development
